Serial Procalcitonin Measurements for Determining Bacterial Infection and Mortality in Cirrhotic Patients With Systemic Inflammatory Response Syndrome
Open Access
- 30 December 2024
- journal article
- liver
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 16 (3) , e00810
Abstract
INTRODUCTION: The utility of serial procalcitonin (PCT) measurements in cirrhotic patients with systemic inflammatory response syndrome (SIRS) is not well understood. The aim of this study was to assess the effectiveness of serial PCT measurements for diagnosing bacterial infections and predicting 30-day mortality in this population. METHODS: We prospectively studied 120 cirrhotic patients with SIRS, 64.2% of whom had bacterial infections. Serial PCT levels were measured within the first 72 hours of admission. RESULTS: Patients with bacterial infections had significantly higher PCT levels at admission, 24 hours, and 72 hours compared with those without infections. PCT values >0.5 ng/mL within 72 hours demonstrated high sensitivity (81.8–87.5%) but moderate specificity (27.9–44.2%) for diagnosing bacterial infections. Serial PCT monitoring, including the 72-hr/baseline ratio and changes in PCT over 72 hours, provided insights into the evolution of bacterial infections and short-term mortality. Patients with a PCT 72-hour/baseline ratio >0.8 had higher 30-day mortality than those with a ratio 50% had lower 30-day mortality than those with increasing levels (23.3% vs 46.7%; odds ratio 0.25, 95% CI 0.08–0.74). Patients with Model for End-Stage Liver Disease scores >15 and bacterial infections who experienced a PCT decrease of P = 0.021). DISCUSSION: Serial PCT measurements within 72 hours of admission are useful for determining bacterial infections and mortality in cirrhotic patients with SIRS. PCT monitoring may optimize antibiotic use and enhance early risk stratification, potentially improving patient outcomes.Keywords
Funding Information
- Faculty of Medicine Siriraj Hospital, Mahidol University (R015633001)
This publication has 34 references indexed in Scilit:
- The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective studyInternational Journal of Infectious Diseases, 2020
- Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)Journal of Hepato-Biliary-Pancreatic Sciences, 2017
- Developing a New Definition and Assessing New Clinical Criteria for Septic ShockJAMA, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysisDiagnostic Microbiology and Infectious Disease, 2014
- Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosisAnnals of Hepatology, 2013
- Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot studyMedicina Intensiva (English Edition), 2012
- Management of bacterial infections in cirrhosisJournal of Hepatology, 2012
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996